1. Home
  2. AADI vs BUJA Comparison

AADI vs BUJA Comparison

Compare AADI & BUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • BUJA
  • Stock Information
  • Founded
  • AADI 2011
  • BUJA 2022
  • Country
  • AADI United States
  • BUJA Malaysia
  • Employees
  • AADI N/A
  • BUJA N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • BUJA Blank Checks
  • Sector
  • AADI Health Care
  • BUJA Finance
  • Exchange
  • AADI Nasdaq
  • BUJA Nasdaq
  • Market Cap
  • AADI 49.0M
  • BUJA 54.3M
  • IPO Year
  • AADI N/A
  • BUJA 2023
  • Fundamental
  • Price
  • AADI $2.11
  • BUJA $10.99
  • Analyst Decision
  • AADI Hold
  • BUJA
  • Analyst Count
  • AADI 3
  • BUJA 0
  • Target Price
  • AADI $1.75
  • BUJA N/A
  • AVG Volume (30 Days)
  • AADI 114.7K
  • BUJA 4.1K
  • Earning Date
  • AADI 11-06-2024
  • BUJA 01-01-0001
  • Dividend Yield
  • AADI N/A
  • BUJA N/A
  • EPS Growth
  • AADI N/A
  • BUJA N/A
  • EPS
  • AADI N/A
  • BUJA N/A
  • Revenue
  • AADI $25,070,000.00
  • BUJA N/A
  • Revenue This Year
  • AADI $8.10
  • BUJA N/A
  • Revenue Next Year
  • AADI $8.54
  • BUJA N/A
  • P/E Ratio
  • AADI N/A
  • BUJA $30.09
  • Revenue Growth
  • AADI 7.80
  • BUJA N/A
  • 52 Week Low
  • AADI $1.21
  • BUJA $10.32
  • 52 Week High
  • AADI $5.70
  • BUJA $12.18
  • Technical
  • Relative Strength Index (RSI)
  • AADI 56.23
  • BUJA 66.75
  • Support Level
  • AADI $1.98
  • BUJA $10.95
  • Resistance Level
  • AADI $2.40
  • BUJA $10.98
  • Average True Range (ATR)
  • AADI 0.11
  • BUJA 0.00
  • MACD
  • AADI 0.01
  • BUJA -0.00
  • Stochastic Oscillator
  • AADI 36.96
  • BUJA 100.00

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About BUJA Bukit Jalil Global Acquisition 1 Ltd.

Bukit Jalil Global Acquisition 1 Ltd is a blank check company.

Share on Social Networks: